Slow Responders to Zepbound Achieve Meaningful Weight Loss Eventually

(MedPage Today) -- NEW ORLEANS--The vast majority of patients with obesity who responded slowly to the once-weekly injectable tirzepatide (Zepbound) achieved meaningful reductions in body weight a year later, a post hoc analysis of the SURMOUNT...